AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06377657 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The HIIT group underwent intervention with high intensity interval training. The second group was treated only with aloe vera supplementation for 12 weeks. A third group underwent a combination of HIIT and supplementation, while a fourth - CON group kept usual activities during the intervention duratino
Study NCT06377657 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Aloe vera
Description: Aloe Vera group was treated only with aloe vera supplementation for 12 weeks.
Study NCT04858178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Tests of sympathetic activation
Description: Cold pressor test of the hand will be used to cause sympathetic activation. Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).
Study NCT04858178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Testing of autonomic dysreflexia
Description: Cold pressor test of the foot and bladder pressor response (in individuals with SCI) will be tested.
Study NCT04858178 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal cord stimulation
Description: Transcutaneous spinal cord stimulation will be applied at T7-L1 spinal segments to assess alterations in autonomic neuroregulation.
Study NCT05748652 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital CBT
Description: An app-based intervention based on principles from cognitive behavioral therapy for anxiety.
Study NCT05748652 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Participants will be provided with psychoeducation which will be delivered digitally upon allocation to the psychoeducation arm.
Study NCT05599568 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise
Description: Either concentric or excentric exercise
Study NCT05247528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MANP
Description: Novel designer peptide to represent a pGC-A/cGMP therapeutic
Study NCT05247528 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Comparator
Study NCT06032845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: a PD-1 immune check inhibitor
Study NCT06032845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib capsules
Study NCT06032845 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Cryoablation is performed under US or CT guidance per Investigator decision.
Study NCT05293392 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally-Tailored COVID-19 Vaccine Uptake Intervention
Description: This is a multi-component intervention to increase COVID-19 vaccine uptake among youth that was co-created with community partners and refined with qualitative feedback from Black and Latino youth and parents. The intervention consists of culturally-tailored educational materials to increase awareness about the COVID-19 vaccine, culturally-sensitive communication strategies employed by pediatric primary care providers and community health workers, and strategies to facilitate and standardize access to the COVID-19 vaccine in the primary care clinic.
Study NCT05293392 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard care includes routine offer of the COVID-19 vaccine and counseling about the COVID-19 vaccine by pediatric primary care providers.
Study NCT04911192 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical fragmentation
Description: patients who will be treated with catheter-directed mechanical fragmentation under fluoroscopy guidance. This group will include patients with absolute contraindication for fibrinolytic therapy
Study NCT04911192 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: In Situ thrombolysis
Description: Group (C) will include the patients who will be treated with bed side administration of low dose of local thrombolytic therapy (In Situ) via a trans-Jugular Swan-Ganz pulmonary artery catheter. with guidance of the pressure waveforms obtained from SGC (Swan-Ganz catheter) and echocardiography guidance for ideal Catheter placement. This group will include the patients with relative contraindications for systemic thrombolysis, contraindications for contrasted administration (patients with renal impairment) and also patients with contraindications for radiation exposure (pregnant women).
Study NCT05864456 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prizvalve Pro™ transcatheter aortic valve system
Description: Transcatheter Aortic Valve Replacement
Study NCT05402371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rencofilstat
Description: Rencofilstat soft gel capsule
Study NCT05402371 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo soft gel capsule
Study NCT05973149 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLH12016
Description: according to the scheme description
Study NCT05747040 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: monitoring
Description: The intervention consists of 48-h monitoring by using two types of monitoring: an objective monitoring, through a class IIa wearable medical device recording four physiological signals, and a subjective monitoring through a questionnaire developed with Microsoft Forms that can be compiled with a smartphone. The monitoring will be conducted during a motor neurorehabilitation treatment, 24 hours before and 24 hours after the treatment at the participant's home. Besides this monitoring, stratification questionnaires will be administered to each participant to be stratified in one of the three categories (absence of pain, nociceptive pain, or neuropathic pain) based on the following timeline:~t0: baseline t1: pre-treatment t2: post-treatment t3: follow-up
Study NCT05941403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Produce Prescription Implementation
Description: Practices make modifications to their usual produce prescription program based on an implementation blueprint. While the exact implementation strategies to be added will be defined based on qualitative data (data collection in progress), possible implementation strategies may include training or technical assistance.
Study NCT05596877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Performing music therapy during a course of pulmonary rehabilitation (25 mins)
Study NCT05326659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benvitimod Cream
Description: Benvitimod cream, 1%, applied twice daily for 12 weeks after enrolment.
Study NCT05326659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, applied twice daily for 12 weeks after enrolment.
Study NCT05028361 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: mRNA COVID-19
Description: ACIP-CDC recommended vaccine
Study NCT05028361 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: IIV4
Description: ACIP recommended vaccine
Study NCT05028361 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo (saline)
Description: Saline Control
Study NCT05814276 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training on non-pharmacological therapies' methodology
Description: The San Rocco study encompasses a training on the non-pharmacological therapies' methodology. It allows the professional caregiver to methodological definition of the non-pharmacological interventions and a comparison of shared readings of the challenging behaviors by the group of colleagues. Participants will follow:~* Five meetings, lasting 11 hours overall, on the multidimensional assessment, the shared readings of behavioral disorders of each person and identification of the objectives through the discussion of cases, and administration of non-pharmacological therapies within the framework of the personalization of the interventions~* Five meetings, lasting five and a half hours, for the supervision of the staff which implement the non-pharmacological therapies.~As usual control group Participants will continue the usual care activities and non-pharmacological interventions already in use in the Nursing Homes without participating in the training.
Study NCT05647278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegoprazan
Description: Tegoprazan 50 mg, tablets, orally, qd given in combination with amoxicillin 750mg capsules, orally, qid for up to 2 weeks.
Study NCT05647278 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: esomeprazole 20 mg, tablets, orally, bid given in combination with amoxicillin 1000mg，clarithromycin 500mg bid，colloidal bismuth pectin 200mg bid for up to 2 weeks.~OR esomeprazole 20 mg, tablets, orally, bis in die given in combination with amoxicillin 750mg capsules, orally, quarter die for up to 2 weeks.
Study NCT05191056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo drink
Description: consume 1 bottle per day for 8 weeks
Study NCT05191056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MelaGene drink
Description: consume 1 bottle per day for 8 weeks
Study NCT06395493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pilates Group
Description: In this study, the participants in the Pilates group will undergo 2 sessions per week, for 12 consecutive weeks.
Study NCT06395493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Group
Description: In this study, the participants in the Exercise group will undergo 2 sessions per week, for 12 consecutive weeks.
Study NCT06395493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Control Group
Description: The participants in the control group, are those who either opt not to do the exercises or are on the waiting list for physiotherapy intervention. Therefore, they will not undergo any intervention for 12 consecutive weeks.
Study NCT05444712 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy + follow up
Description: * Chemotherapy administrated every 3 weeks for 6 cycles according to local investigator's choice based on usual practices.~* An intermediate evaluation will be performed after four cycles by PET-CT (or CT-Scan for non-avid PTCL)~* A post-induction evaluation by PET-CT or CT-Scan will be done between 3 and 5 weeks after the last chemotherapy drug administration for all patients~* A last evaluation by PET-CT or CT-Scan will be done between 08 and 12 weeks after the post-induction for all patients
Study NCT05444712 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy + ASCT + follow up
Description: * Chemotherapy administrated every 3 weeks for 6 cycles according to local investigator's choice based on usual practices.~* An intermediate evaluation will be performed after four cycles by PET-CT (or CT-Scan for non-avid PTCL)~* The fifth or sixth cycles should be used as stem-cell mobilizing chemotherapy for patients with ASCT strategy~* A post-induction evaluation by PET-CT or CT-Scan will be done between 3 and 5 weeks after the last chemotherapy drug administration for all patients~* Patients with in Complete Response after 6 cycles will receive a High Dose Therapy as conditioning regimen before transplantation~* A last evaluation by PET-CT or CT-Scan will be done between 08 and 12 weeks after the post-induction for all patients
Study NCT04726332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XL102
Description: oral doses of XL102
Study NCT04726332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: fulvestrant 500 mg administered as an intramuscular (IM) injection every 2 weeks for the first 3 doses and then every 4 weeks.
Study NCT04726332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone
Description: abiraterone 1000 mg administered orally once daily.
Study NCT04726332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: prednisone 5 mg administered orally twice daily.
Study NCT06549803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: skin bond
Description: In the skin bond group, fascia closure is performed for incision sites of 10 mm or more, and skin bond is sufficiently applied after subcuticular suture.~For incision sites less than 10 mm, subcuticular closure is performed without closing the fascia, and then skin bond is applied.
Study NCT06549803 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: skin stapler
Description: In the skin stapler group, fascia closure is performed on incision sites larger than 10 mm, and the skin is closed at 2-3 mm intervals using a stapler.~For incision sites less than 10 mm, skin closure is performed using a skin stapler without closing the fascia.
Study NCT05242432 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26/protein preF RSV Vaccine
Description: Ad26/protein preF RSV vaccine will be administered as an IM injection.
Study NCT05242432 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo will be administered as an IM injection
Study NCT05403398 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: B. subtilis CU1
Description: 2 billion CFUs daily, for 4 weeks
Study NCT05400785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Circadian Rhythms for Mood (CRM) application - Active
Description: The study subjects participating in this clinical trial wear wearable activity tracker 24 hours a day for a continuous period of time and run the CRM app once a day to check their conditions (feelings, vitality, sleep, etc.) in the Daily Symptom Assessment (eMoodChart). The active intervention group are provided with mood prediction results and instructions as feedback through the 'life report' and push notification in the application.
Study NCT05400785 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Circadian Rhythms for Mood (CRM) application - Sham
Description: The study subjects assigned to the sham intervention group are provided with feedbacks operated by dummy algorithm. The application is visually indistinguishable from active CRM, and it is designed to minimize behavioral change.
Study NCT05320679 — intervention group
Intervention type: OTHER
Intervention: Implementation of Questionnaire
Description: Compartment of results of questionnaires which already been used in literature and results of developing Pain Related Avoidance of Movement Questionnaire
Study NCT06157710 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital intervention through modules
Description: * Introduction~* Goal Setting Techniques~* Motivation~* Barriers to Action~* Managing Maladaptive Thoughts and Beliefs~* Value Clarification~* Moving Forward
Study NCT05820958 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shantali massage
Description: The tactile contact of a mother with the newborn was intensified by means of Shantali massage applied at least 2 times a day, 10 min. Additional, spontaneous sessions were allowed as well. This started on the 3rd day after delivery and lasted until the end of the 12th week after delivery. A total of 169 mandatory sessions should have been provided plus spontaneous sessions, if any.~The order of application:~* face and chest; 4 types of movements 10reps each;~* upper extremity; 4 types of movements, 10 reps each (left and right separately);~* abdomen; 2 types of movements, 10 reps each;~* lower extremity; 3 types of movements, 10 reps each (left and right separately);~* back; 2 types of movements, 10 reps each;~* final integration; 3 types of movements, 10 reps each.
Study NCT06267963 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral [14C]PF-07220060
Description: A single oral dose of \[14C\]PF-07220060, will be administered as a liquid formulation in Cohort 1.
Study NCT06267963 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral PF-07220060
Description: A single oral dose of PF-07220060, will be administered as a liquid formulation in Cohort 2.
Study NCT06267963 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV [14C] PF-07220060
Description: A single IV infusion of \[14C\]PF-07220060 will be administered in Cohort 2 at Tmax after the administration of the unlabeled oral dose.
Study NCT05398614 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SENL101
Description: Patients will be treated with CD7 CAR-T cells
Study NCT06294080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dance
Description: Exercise intervention
Study NCT06294080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: Exercise intervention
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Bioelectrical impedance Analysis (BIA)
Description: Bioelectrical impedance analysis (BIA) is a method for estimating body composition, in particular, body fat and muscle mass, where a weak electric current flows through the body and the voltage is measured in order to calculate the impedance (resistance) of the body. BIA will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: D3-Creatine Dilution (D3Cr)
Description: The D3-Creatine dilution method is a safe and noninvasive measure of skeletal muscle mass that has previously been validated in adults, neonates, healthy children, and children. D3-Creatine Dilution will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 6-Minute Walk Test (6MWT)
Description: Cardiovascular fitness will be measured with the 6-minute walk test (6MWT). 6MWT will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Timed Up and Go (TUG)
Description: Balance and mobility will be assessed by the timed-up-and-go test (TUG). TUG will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 30-second Sit-to-Stand (STS)
Description: Strength and muscular function will be evaluated by modified 30-second sit-to-stand (STS). STS will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hand Grip Strength (GS)
Description: Strength and muscular function will be evaluated by grip strength (GS). GS will be done at baseline, during the study related to routine medical imaging, and end of the study.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: PBTL p16 expression
Description: Peripheral Blood biospecimen for PBTL p16 expression will be used for the assessment of biological aging. Blood biospecimens will be collected at baseline and end of the study for PBTL p16 analysis.
Study NCT05823740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CT, MR and PET Imaging
Description: Participants will undergo routine imaging with either computed tomography (CT), Magnetic Resonance Imaging (MRI) of the chest or abdomen, or whole-body positron emission tomography (PET) scan. Skeletal muscle mass and fat mass will be calculated at several different vertebral levels from imaging studies.
Study NCT05179993 — intervention group
Intervention type: OTHER
Intervention: Microplastics
Description: Detection of microplastics as a yes/no value
Study NCT06203522 — intervention group
Intervention type: PROCEDURE
Intervention: Data collection of successful completion of MRI
Description: age, sex, autistic disorders, epilepsy, polyhandicap, non-autistic neurodevelopmental disorders, success of MRI procedure
Study NCT05261854 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pressure biofeedback
Description: Deep cervical flexor training by using preesure biofeedback will be given 5 days a week for 6 week Conventional exercise for deep cervical muscle training will be given 5 days a week for 6 weeks
Study NCT05261854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional exercises for deep cervical muscle training
Description: Conventional exercise for deep cervical muscle training will be given 4 days a week for 6 weeks
Study NCT04384237 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser-aided CSF
Description: After injection 2% lidocaine with 1:80.000 epinephrine concentration in labial and lingual vestibule the fiberotomy is carried out by inserting a 9 x 0.5 mm laser tip into the gingival sulcus with an angle of 10-15º to the radicular surface
Study NCT04384237 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional CSF
Description: After injection 2% lidocaine with 1:80.000 epinephrine concentration in labial and lingual vestibule the fiberotomy is carried out by inserting a surgical blade (#11)into the gingival sulcus at an angle of 10-15º to the radicular surface
Study NCT04290845 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relief-Hybrid
Description: A 9-week behavioral intervention for primary care patients designed to reduce depression and pain-related disability.
Study NCT05205759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bamlanivimab Etesevimab
Description: Single intravenous infusion of bamlanivimab 700 mg and etesevimab 1400 mg, administered together \[1 bamlanivimab vial (700 mg/20 mL) and 2 etesevimab vials (700 mg/20 mL)\] in a 250-mL prefilled 0.9% Sodium Chloride infusion bag over one hour.
Study NCT05205759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotrovimab
Description: Single intravenous infusion of sotrovimab 500 mg (500 mg/8 mL), administered in 100 mL prefilled 0.9% sodium chloride injection infusion solution over 1/2 hour.